Zobrazeno 1 - 10
of 144
pro vyhledávání: '"Trial reporting"'
Autor:
Luthman, Johanna, author
Publikováno v:
Family and Feuding at the Court of James I : The Lake and Cecil Scandals, 2023.
Externí odkaz:
https://doi.org/10.1093/oso/9780192865786.003.0011
Autor:
Wittchen Maria Bendix
Publikováno v:
Nordicom Review, Vol 44, Iss 1, Pp 106-122 (2023)
The trial of amateur submarine builder Peter Madsen for the murder of the Swedish journalist Kim Wall was one of the most publicised trials in recent Danish history. Through in-depth interviews with ten prominent Danish reporters who covered the tria
Externí odkaz:
https://doaj.org/article/0e765b6cb83b4625a2000c140b4501b6
Autor:
Claire Glenton, Benedicte Carlsen, Brita Askeland Winje, Renske Eilers, Manuela Dominique Wennekes, Tammy C. Hoffmann, Simon Lewin, The VITAL Consortium
Publikováno v:
Health Research Policy and Systems, Vol 20, Iss 1, Pp 1-8 (2022)
Abstract Background The COVID-19 pandemic has led to an increased interest in communication with the public regarding vaccination. Our recent Cochrane qualitative evidence synthesis points to several factors that could influence the implementation an
Externí odkaz:
https://doaj.org/article/1162244a9a454d169c09bd6d37b5255a
Autor:
Nicholas J. DeVito, Henry Drysdale
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-3 (2022)
Abstract A recent publication in BMC Infectious Diseases concerning the use of convalescent plasma for the treatment of COVID-19 had a number of major issues. This correspondence details specific instances of unclear reporting as well as major omissi
Externí odkaz:
https://doaj.org/article/73b4ce7bcd63409fb97afc8d2fbb42ef
Autor:
Jan M. Sargeant, Mikayla Plishka, Audrey Ruple, Laura E. Selmic, Sarah C. Totton, Ellen R. Vriezen
Publikováno v:
Journal of Veterinary Internal Medicine, Vol 35, Iss 4, Pp 1957-1971 (2021)
Abstract Background Comprehensive reporting of clinical trials is essential to allow the trial reader to evaluate the methodological rigor of the trial and interpret the results. Since publication of the updated Consolidated Standards of Reporting Tr
Externí odkaz:
https://doaj.org/article/6c4800562ffb459d8caf879bdc97a6f4
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-4 (2020)
Abstract The FDA Amendments Act (FDAAA) required that information for certain clinical trials, such as details about study design features and endpoints, as well as results, be publicly reported in ClinicalTrials.gov . We conducted a cross-sectional
Externí odkaz:
https://doaj.org/article/426fb91d70c44657bd31e19a038bf6db
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-12 (2020)
Abstract Background In a randomized crossover trial, each participant is randomized to a sequence of treatments and treatment effect is estimated based on within-individual difference because each participant serves as his/her own control. This featu
Externí odkaz:
https://doaj.org/article/b1f780a878aa4bb786c1224a99cc5dea
Publikováno v:
BMC Medical Research Methodology, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Most clinical trials with time-to-event primary outcomes are designed assuming constant event rates and proportional hazards over time. Non-constant event rates and non-proportional hazards are seen increasingly frequently in tria
Externí odkaz:
https://doaj.org/article/21c8646b7b5a4c28879fb48fd0ace7eb
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nielsen, Sabrina
Background and Objectives: The average treatment effect estimate from a randomized controlled trial (RCT) may not be valid for deciding what treatment is best for individual patients with specific characteristics. Characteristics may include contextu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cab04afc96e77a9d5186a75b03f4803d
